Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Ran Chen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ran Chen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Unlocking MedTech Success in China: Why a Tech-Forward Partner Like Pure Global is Your Key to Streamlining Global Market Access.

2:26
 
Share
 

Manage episode 522298331 series 3684506
Content provided by Ran Chen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ran Chen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this episode of MedTech Global Insights, we explore the paradigm shift in global market access strategy. We move beyond the traditional, fragmented approach of managing regulatory hurdles country by country and dive into the rise of integrated, technology-driven consulting firms. These firms are not just advisors; they are end-to-end partners with a clear mission to streamline global expansion. We discuss how leveraging a single, centralized process combined with in-country expertise and advanced AI can transform a complex, multi-market launch into a manageable and efficient operation. This episode is for any MedTech or IVD leader who is tired of regulatory bottlenecks and is looking for a modern, strategic path to accessing over 30 global markets, from the Americas to Asia Pacific. Consider this common pain point: A promising MedTech scaleup spends 18 months and a significant portion of its budget trying to enter the Brazilian market, only to have its technical dossier rejected by ANVISA due to a subtle, region-specific data requirement they missed. This single oversight delays revenue, drains resources, and gives competitors a critical advantage. This episode explains how to avoid such pitfalls. What You'll Learn: * Why is a 'single process, multiple markets' approach a game-changer for MedTech scaleups? * How can AI-powered tools dramatically reduce the time and cost of technical dossier submissions? * What are the hidden risks of not having dedicated local representation in key markets like South Korea or Mexico? * How can you strategically select the best initial markets for expansion based on your existing approvals? * What does effective post-market surveillance look like in a rapidly changing global regulatory landscape? * How does a tech-forward firm turn regulatory compliance from a cost center into a competitive advantage? * What are the key differences between a traditional consultant and a modern, integrated regulatory partner? For more information, contact us at [email protected] or visit https://pureglobal.com/.
  continue reading

116 episodes

Artwork
iconShare
 
Manage episode 522298331 series 3684506
Content provided by Ran Chen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ran Chen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this episode of MedTech Global Insights, we explore the paradigm shift in global market access strategy. We move beyond the traditional, fragmented approach of managing regulatory hurdles country by country and dive into the rise of integrated, technology-driven consulting firms. These firms are not just advisors; they are end-to-end partners with a clear mission to streamline global expansion. We discuss how leveraging a single, centralized process combined with in-country expertise and advanced AI can transform a complex, multi-market launch into a manageable and efficient operation. This episode is for any MedTech or IVD leader who is tired of regulatory bottlenecks and is looking for a modern, strategic path to accessing over 30 global markets, from the Americas to Asia Pacific. Consider this common pain point: A promising MedTech scaleup spends 18 months and a significant portion of its budget trying to enter the Brazilian market, only to have its technical dossier rejected by ANVISA due to a subtle, region-specific data requirement they missed. This single oversight delays revenue, drains resources, and gives competitors a critical advantage. This episode explains how to avoid such pitfalls. What You'll Learn: * Why is a 'single process, multiple markets' approach a game-changer for MedTech scaleups? * How can AI-powered tools dramatically reduce the time and cost of technical dossier submissions? * What are the hidden risks of not having dedicated local representation in key markets like South Korea or Mexico? * How can you strategically select the best initial markets for expansion based on your existing approvals? * What does effective post-market surveillance look like in a rapidly changing global regulatory landscape? * How does a tech-forward firm turn regulatory compliance from a cost center into a competitive advantage? * What are the key differences between a traditional consultant and a modern, integrated regulatory partner? For more information, contact us at [email protected] or visit https://pureglobal.com/.
  continue reading

116 episodes

כל הפרקים

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play